“… 3 , 4 Conversely, ophthalmologists have reported several cases of worsening reticular corneal epithelial edema associated with netarsudil use in eyes with predisposing risk factors or prior surgeries that include corneal endothelial keratoplasty, penetrating keratoplasty, Fuchs endothelial corneal dystrophy (FECD) undergoing Descemetorhexis without endothelial keratoplasty (DWEK)/Descemet stripping only (DSO), Descemet stripping endothelial keratoplasty, uveitis, pseudophakic bullous keratopathy, glaucoma tube shunt, and trabeculectomy. 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 , 14 Most of these cases were described as corneal epithelial reticular honeycomb edema changes that completely resolved with cessation of netarsudil. Guttata-like endothelial changes with polymegathism and indistinct borders on specular microscopy have also been described, 15 but other studies have not found significant changes in endothelial cell metrics.…”